Erlotinib Completed Phase 1 Trials for Extrahepatic Bile Duct Cancer / Small Intestine Cancer / Cancer of the Gallbladder / Malignant Neoplasm of Pancreas / Periampullary Adenocarcinoma / Liver Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00987766Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer